02/13/2025 5:22 AM | Shuttle Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
02/06/2025 6:33 PM | Richards Steven M (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 5/A | |
02/06/2025 6:34 PM | Schafer Joshua (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 5/A | |
02/05/2025 3:55 PM | Brown Milton (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
02/03/2025 6:30 PM | Richards Steven M (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
02/03/2025 6:30 PM | Schafer Joshua (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
01/24/2025 8:39 AM | Shuttle Pharmaceuticals (Filer)
| Form 424B3 | |
01/23/2025 11:15 PM | Shuttle Pharmaceuticals (Filer)
| Form EFFECT | |
01/21/2025 7:40 PM | Shuttle Pharmaceuticals (Filer)
| Form RW | |
01/21/2025 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/15/2025 5:37 AM | Shuttle Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
Get the Latest News and Ratings for SHPH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Shuttle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
01/07/2025 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/19/2024 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/26/2024 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2024 4:16 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2024 4:01 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024 7:57 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/31/2024 11:05 AM | Shuttle Pharmaceuticals (Filer)
| Form 424B4 | |
10/29/2024 11:15 PM | Shuttle Pharmaceuticals (Filer)
| Form EFFECT | |
10/29/2024 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/28/2024 3:05 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/28/2024 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2024 7:49 AM | Shuttle Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
10/25/2024 7:52 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2024 8:06 AM | Shuttle Pharmaceuticals (Filer)
| Form S-1/A | |
10/17/2024 4:17 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/09/2024 4:00 PM | Jung Mira (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 5:04 AM | Shuttle Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
09/13/2024 7:25 PM | Shuttle Pharmaceuticals (Filer)
| Form 424B3 | |
09/13/2024 4:00 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/10/2024 4:23 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/04/2024 3:26 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/03/2024 8:51 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-K/A | |
09/03/2024 8:52 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q/A | |
09/03/2024 8:54 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/28/2024 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 5:08 AM | Shuttle Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/07/2024 7:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2024 8:45 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/16/2024 3:59 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 4:42 PM | Lorber Timothy J. (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
Watch This Robotics Demo Before March 17th (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
06/18/2024 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 5:12 AM | Shuttle Pharmaceuticals (Filer)
| Form PRE 14A | |
05/22/2024 3:15 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 4:01 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024 9:05 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2024 3:36 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/05/2024 4:06 PM | Shuttle Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
03/22/2024 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/22/2024 5:07 AM | Shuttle Pharmaceuticals (Filer)
| Form 424B3 | |
03/21/2024 4:28 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/14/2024 4:02 PM | Senanayake Chris (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 5:18 PM | Shuttle Pharmaceuticals (Issuer) Vander Hoek Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |